首页> 外文期刊>The Journal of Urology >Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases.
【24h】

Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases.

机译:柔性输尿管镜和:YAG碎石术在抗凝病例中治疗肾内结石的安全性和有效性。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: We compared perioperative outcomes in patients undergoing ureterorenoscopy and Ho:YAG lithotripsy for renal calculi with or without anticoagulation. MATERIALS AND METHODS: We reviewed the records of all patients undergoing flexible ureterorenoscopy and Ho:YAG lithotripsy for renal calculi at 2 institutions from 2001 to 2007. We identified 37 patients on anticoagulation with Coumadin, clopidogrel or aspirin in whom anticoagulation therapy was not discontinued before surgery. Data on the anticoagulation group were retrospectively compared to those on a contemporary matched cohort of 37 controls without anticoagulation who underwent a similar operative procedure. The 2 groups were compared with regard to the stone-free rate, and intraoperative and postoperative complications with specific reference to bleeding and thromboembolism. RESULTS: The 2 groups were matched for stone size, stone location, number of stones, bilateral procedures and concomitant ureteral stones. Anticoagulation group patients were older (58.2 vs 50.4 years, p = 0.0209) and had a greater American Society of Anesthesiologists score (2.8 vs 1.9, p <0.0001) compared to the control group. No procedure had to be terminated in the anticoagulation group due to poor visibility from bleeding. The median postoperative hemoglobin decrease was greater in the anticoagulation group than in the control group (0.6 vs 0.2 gm/dl, p <0.0001). The stone-free rate (81.1% vs 78.4%, p = 0.7725), intraoperative complications (0% vs 3%, p = 0.3140), postoperative complications (11% vs 5%, p = 0.3943) and hemorrhagic or thromboembolic adverse events were comparable in the 2 groups. CONCLUSIONS: When necessary, ureterorenoscopy and Ho:YAG lithotripsy can be performed safely and efficaciously for renal calculi in patients on anticoagulation therapy without the need for perioperative manipulation.
机译:目的:我们比较了接受输尿管镜和Ho:YAG碎石术治疗肾结石伴或不伴抗凝治疗患者的围手术期结局。材料与方法:我们回顾了2001年至2007年在2个机构中接受柔性输尿管镜和Ho:YAG碎石术治疗肾结石的所有患者的记录。我们确定了37例曾接受香豆素,氯吡格雷或阿司匹林抗凝治疗的患者,这些患者之前未停用抗凝治疗手术。回顾性地将抗凝组的数据与接受类似手术程序的37例未进行抗凝的当代对照人群的数据进行比较。比较两组的结石发生率,术中和术后并发症,特别是出血和血栓栓塞。结果:两组患者的结石大小,结石位置,结石数目,双侧手术和输尿管结石均匹配。与对照组相比,抗凝组患者年龄更大(58.2 vs 50.4岁,p = 0.0209),并且美国麻醉医师学会评分更高(2.8 vs 1.9,p <0.0001)。由于出血的可见性差,抗凝组无需终止任何程序。抗凝治疗组的平均术后血红蛋白减少量高于对照组(0.6 vs 0.2 gm / dl,p <0.0001)。无结石发生率(81.1%vs 78.4%,p = 0.7725),术中并发症(0%vs 3%,p = 0.3140),术后并发症(11%vs 5%,p = 0.3943)和出血性或血栓栓塞性不良事件在两组中具有可比性。结论:必要时,可以对接受抗凝治疗的患者的肾结石安全,有效地进行输尿管镜检查和Ho:YAG碎石术,而无需围手术期操作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号